Understanding clinical implementation coordinators' experiences in deploying evidence-based interventions.

Purpose The fluoroquinolone restriction for the prevention of Clostridioides difficile infection (FIRST) trial is a multisite clinical study in which sites carry out a preauthorization process via electronic health record–based best-practice alert (BPA) to optimize the use of fluoroquinolone antibio...

Full description

Bibliographic Details
Published in:American Journal of Health-System Pharmacy Vol. 81; no. 4; pp. 120 - 129
Main Authors: Hernandez, Sara E, Solomon, Demetrius, Moon, Jukrin, Parmasad, Vishala, Wiegmann, Douglas, Bennett, Nick T, Ferren, Ryan S, Fitzsimmons, Alec J, Lepak, Alexander J, O'Horo, John C, Pop-Vicas, Aurora E, Schulz, Lucas T, Safdar, Nasia
Format: research tables/charts Journal Article
Published: Oxford University Press / USA 2/15/2024
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175366324&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 175366324
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10792082
        1X3
      jtl: American Journal of Health-System Pharmacy
      issn: 10792082
      maglogo: N
    pubinfo:
      dt: 2/15/2024
      vid: 81
      iid: 4
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        175366324
        175366324
        175366324
        10.1093/ajhp/zxad272
        175366324
      ppf: 120
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Understanding clinical implementation coordinators' experiences in deploying evidence-based interventions.
      aug:
        au:
          Hernandez, Sara E
          Solomon, Demetrius
          Moon, Jukrin
          Parmasad, Vishala
          Wiegmann, Douglas
          Bennett, Nick T
          Ferren, Ryan S
          Fitzsimmons, Alec J
          Lepak, Alexander J
          O'Horo, John C
          Pop-Vicas, Aurora E
          Schulz, Lucas T
          Safdar, Nasia
        affil: School of Pharmacy, University of Wisconsin–Madison , Madison, WI , USA
      sug:
        subj:
          Clostridium Infections Prevention and Control
          Antiinfective Agents, Fluoroquinolone Therapeutic Use
          Antimicrobial Stewardship
          Attitude of Health Personnel Evaluation
          Work Experiences Evaluation
          Professional Role Evaluation
          Health Services Accessibility Evaluation
          Implementation Science
          Medical Practice, Evidence-Based
          Human
          Content Analysis
          Semi-Structured Interview
          Diaries
          Conceptual Framework
          Personnel Staffing and Scheduling
          Empowerment
          Decision Support Systems, Clinical
          Funding Source
          Diffusion of Innovation
          Descriptive Statistics
      ab: Purpose The fluoroquinolone restriction for the prevention of Clostridioides difficile infection (FIRST) trial is a multisite clinical study in which sites carry out a preauthorization process via electronic health record–based best-practice alert (BPA) to optimize the use of fluoroquinolone antibiotics in acute care settings. Our research team worked closely with clinical implementation coordinators to facilitate the dissemination and implementation of this evidence-based intervention. Clinical implementation coordinators within the antibiotic stewardship team (AST) played a pivotal role in the implementation process; however, considerable research is needed to further understand their role. In this study, we aimed to (1) describe the roles and responsibilities of clinical implementation coordinators within ASTs and (2) identify facilitators and barriers coordinators experienced within the implementation process. Methods We conducted a directed content analysis of semistructured interviews, implementation diaries, and check-in meetings utilizing the conceptual framework of middle managers' roles in innovation implementation in healthcare from Urquhart et al. Results Clinical implementation coordinators performed a variety of roles vital to the implementation's success, including gathering and compiling information for BPA design, preparing staff, organizing meetings, connecting relevant stakeholders, evaluating clinical efficacy, and participating in the innovation as clinicians. Coordinators identified organizational staffing models and COVID-19 interruptions as the main barriers. Facilitators included AST empowerment, positive relationships with staff and oversight/governance committees, and using diverse implementation strategies. Conclusion When implementing healthcare innovations, clinical implementation coordinators facilitated the implementation process through their roles and responsibilities and acted as strategic partners in improving the adoption and sustainability of a fluoroquinolone preauthorization protocol.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N